Data as of 2:30pm ET
| -0.0021 / -0.23%|
The 5 analysts offering 12-month price forecasts for Lexicon Pharmaceuticals Inc have a median target of 3.00, with a high estimate of 3.50 and a low estimate of 2.70. The median estimate represents a +233.30% increase from the last price of 0.90.
The current consensus among 8 polled investment analysts is to Buy stock in Lexicon Pharmaceuticals Inc. This rating has held steady since January, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.